Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The EPH receptor family comprises the largest group of receptor tyrosine kinases (RTKs), with at least 15 distinct members identified in humans. These receptors play critical roles in cell positioning, migration, tissue patterning, axon guidance, and angiogenesis during development and disease processes. Activation requires direct cell-cell contact and leads to bidirectional signaling, influencing both receptor-expressing and ligand-expressing cells. Dysregulation is implicated in various cancers, making them therapeutic targets.
Inhibition of ligand binding or kinase activity, blocking downstream signaling pathways
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EPH Receptor Family Kinase (EPH Receptors).